[Contribution to the biochemical concept of experimental psychoses. VII. Action of N-thiodiphenyl-carbamyl piperazine (5501 MD) and of chlorpromazine on disorders of fluid balance and of cerebral metabolism induced by chronic administration of LSD 25 in rabbits in vivo].
D000818:Animals; D001826:Body Fluids / Q000378:metabolism*; D001921:Brain / Q000378:metabolism*; D002746:Chlorpromazine / Q000494:pharmacology*; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology*; D010640:Phenothiazines / Q000031:analogs & derivatives; D010879:Piperazines; D011605:Psychoses, Substance-Induced; D011618:Psychotic Disorders; D011817:Rabbits; D014882:Water-Electrolyte Balance
D010640:Phenothiazines; D010879:Piperazines; D008238:Lysergic Acid Diethylamide; C031637:phenothiazine; D002746:Chlorpromazine
BODY FLUID BALANCE; BRAIN/metabolism; CHLORPROMAZINE/effects; LYSERGIC ACID DIETHYLAMIDE/effects; PHENOTHIAZINE/related compounds; PSYCHOSES, TOXIC/experimental
Contribution à un concept biochimique des psychoses expérimentales VII. Action du N thiodiphénylcarbamyl pipérazine (5501 MD) et de la chlorpromazine sur les perturbations du bilan humoral et du métabolisme cérébral provoquées par l'administration chronique de LSD 25 chez le lapin in vivo.